ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ATROVENT HFA
Asthma/COPD
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

ATROVENT HFA Rx

Generic Name and Formulations:
Ipratropium bromide 17micrograms/inh; metered dose inhaler; CFC-free.

Company:
Boehringer Ingelheim Pharmaceuticals

Therapeutic Use:

Indications for ATROVENT HFA:

Bronchospasm associated with chronic bronchitis and emphysema.

Adult:

2 inh 4 times daily; max 12 inh/day.

Children:

Not established.

Contraindications:

Allergy to atropine or its derivatives.

Warnings/Precautions:

Not for primary treatment of acute attack. Avoid eyes. Narrow-angle glaucoma. GU obstruction. Pregnancy (Cat.B). Nursing mothers.

Interactions:

Caution with other anticholinergics.

See Also:

Ipratropium Bromide Inhalation Solution

Pharmacological Class:

Anticholinergic.

Adverse Reactions:

Bronchitis, COPD exacerbation, dyspnea, headache, anticholinergic effects; paradoxical bronchospasm, hypersensitivity reactions.

Note:

Formerly known under the brand name Atrovent.

Generic Availability:

HFA (NO); soln (YES)

How Supplied:

Inhaler—12.9g (200 inh); inhalation soln—contact supplier

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs